share_log

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

今日最大的盤前股票交易商:週四10大漲跌股
InvestorPlace ·  2021/09/23 07:36

Good morning, investor! We’re diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday!

早上好,投資者!我們今天再次回到股市,看看週四最大的盤前漲幅!

Source: Shutterstock

消息來源:Shutterstock

We’ve got loads of stock news to discuss as clinical trials, criminal probes, stock offerings, and more move the market.

我們有大量的股票新聞要討論,因為臨牀試驗、刑事調查、股票發行等等都在推動市場。

Let’s talk about those pre-market stock movers now!

現在讓我們來談談那些開盤前的股票推動者吧!

Pre-Market Stock Movers: 10 Top Gainers

盤前股票交易商:10大漲幅最大的股票

  1. Amplitude Healthcare (NASDAQ:AMHC) stock is rocketing more than 79% higher on approval from shareholders for its merger with Jasper Therapeutics.

  2. MEDIROM Healthcare (NASDAQ:MRM) shares are soaring nearly 30% after releasing its Key Performance Indicators for August 2021.

  3. Digital Brands Group (NASDAQ:DBGI) stock is climbing over 20% despite a lack of news this morning.

  4. Datasea (NASDAQ:DTSS) shares are increasing roughly 15% on no clear news this morning.

  5. Xenetic Biosciences (NASDAQ:XBIO) stock is gaining more than 13% following a rally on Wednesday.

  6. Regencell Bioscience (NASDAQ:RGC) shares are rising over 10% in pre-market trading today.

  7. Solid Biosciences (NASDAQ:SLDB) stock is sitting 10% higher as it prepares to provide an update on clinical trial data this morning.

  8. PAVmed (NASDAQ:PAVM) shares are jumping more than 9% after one of its subsidiaries joined the Microsoft for Startups program.

  9. Northern Dynasty Minerals (NYSEAMERICAN:NAK) stock is getting a 9% boost as chatter on social media heats up.

  10. Camber Energy (NYSEAMERICAN:CEI) shares are recovering over 8% after falling on Wednesday.

  1. 振幅醫療(納斯達克:AMHC)在獲得股東批准後,其股價飆升了79%以上賈斯珀治療公司.

  2. MEDIROM醫療保健(納斯達克:MRM)在發佈了2021年8月的關鍵業績指標後,股價飆升了近30%。

  3. 數字品牌集團(納斯達克:DBGI)股價攀升超過20%,儘管今早缺乏消息。

  4. DATASEA(納斯達克:DTSS)股價在今天上午沒有明確消息的情況下上漲了約15%。

  5. 遺傳生物科學(納斯達克:XBIO)股價在週三反彈後上漲了13%以上。

  6. 腦再生科技(納斯達克:研資局)股價在今天的盤前交易中上漲了10%以上。

  7. 固體生物科學(納斯達克:SLDB)股價上漲10%,因為該公司準備在今天上午提供最新的臨牀試驗數據。

  8. PAVmed(納斯達克:PAVM)在其一家子公司加入微軟的創業計劃後,其股價躍升了9%以上。

  9. 北朝礦產(NYSEAMERICAN:NAK)隨着社交媒體上的討論升温,股價上漲了9%。

  10. 弧形能源(NYSEAMERICAN:CEI)股價在週三下跌後回升逾8%。

10 Top Losers

十大輸家

  1. Eargo (NASDAQ:EAR) stock is plummeting more than 58% following news of a criminal probe and the company withdrawing its guidance for 2021.

  2. Magal Security System (NASDAQ:MAGS) shares are diving over 30% on no obvious news this morning.

  3. Synlogic (NASDAQ:SYBX) stock is falling 10% after announcing pricing for a public stock offering.

  4. Marin Software (NASDAQ:MRIN) shares are taking a more than 8% beating as it pulls back from a strong rally on Wednesday.

  5. Aethlon Medical (NASDAQ:AEMD) stock is dropping almost 8% following a rally yesterday.

  6. Vale (NYSE:VALE) shares are decreasing over 7%

  7. Ensysce Biosciences (NASDAQ:ENSC) stock is slipping more than 6% after revealing dividend prices yesterday boosted the shares.

  8. Nanoviricides (NYSEAMERICAN:NNVC) shares are declining over 6%, which continues negative movement from yesterday.

  9. BioCardia (NASDAQ:BCDA) stock is dipping more than 5% after gaining during trading hours on Wednesday.

  10. Aluminum Corp. of China (NYSE:ACH) shares close out our pre-market stock movers down over 4% following a major rally yesterday.

  1. 厄戈(納斯達克:耳朵在一項刑事調查和該公司撤回2021年指導的消息傳出後,該公司股價暴跌逾58%。

  2. Magal安全系統(納斯達克:雜誌)股價今天上午在沒有明顯消息的情況下暴跌超過30%。

  3. 語法(納斯達克:SYBX)宣佈公開發行股票定價後,股價下跌10%。

  4. Marin軟件(納斯達克:MRIN)股價從週三的強勁反彈中回落,跌幅超過8%。

  5. 艾斯隆醫療(納斯達克:AEMD)股票下跌了近8%繼昨天的一次反彈之後.

  6. 谷谷紐約證券交易所代碼:淡水河谷)股價跌幅超過7%

  7. Ensysce生物科學(納斯達克:ENSC)股價下跌超過6%,昨日公佈的股息價格提振了股價。

  8. 納米殺菌劑(NYSEAMERICAN:NNVC)股價下跌超過6%,延續了昨日以來的負面走勢。

  9. 生物心(納斯達克:BCDA)股價在週三交易時段上漲後,跌幅超過5%。

  10. 中國鋁業股份有限公司紐約證券交易所代碼:阿奇)股價在昨天大幅上漲後,收盤前股價下跌超過4%。

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

在出版之日,威廉·懷特沒有(直接或間接)持有本文所述證券的任何頭寸。本文表達的觀點是作者的觀點,以InvestorPlace.com為準出版指南.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論